
Navamedic ASA Expands Alflorex® distribution
On the 24th of January 2020, Navamedic ASA announced that they have entered into an agreement with Alimentary Health to expand the distribution of Alflorex® in the Netherlands and Denmark. Alflorex® is a unique product for irritable bowel syndrome (IBS) and is classified as a medical device. Alflorex® was launched in Denmark in December 2019 and will be launched in the Netherlands in 2H 2020. >>
Reiten & Co